By Kevin Madagan
Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.
The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures polyethylene glycol (PEG) reagents, which are used in advanced biopharmaceutical and therapeutic products.
This week, the U.S. Attorney’s Office for the District of Colorado (“USAO”) announced that it entered into a series of interrelated settlement agreements with companies that provide intraoperative neuromonitoring (“IONM”) services, the companies’ founder, a neurosurgeon, and a businessman affiliated with the companies. IONM services involve the use of electrodes to monitor a patient’s nervous…
LSR3 v New South Wales [2024] NSWSC 1570 (Link to Caselaw).
With thanks to Robert Algie for drawing attention to this decision.
By these proceedings the plaintiff sought compensation for alleged historic child abuse. The plaintiff sued multiple defendants including the State of New South Wales and the South East Sydney Local Health District of Caringbah (SESLHD).…
The Federal Court recently refused to order a defendant to produce samples of cell culture because there was no “reasonable possibility” that testing the samples would yield evidence of patent infringement. In pharmaceutical patent cases, testing samples of a defendant’s product – or samples from a defendant’s process – can lead to crucial evidence of…
The Law
The Corporate Transparency Act (the CTA), a law enacted by Congress requiring certain business entities to disclose beneficial ownership information (a BOI Report) to FinCEN, went into effect on January 1, 2024, and obligates reporting companies formed before January 1, 2024, to file BOI Reports on or before January 1, 2025.
The Challenge…
Barclay v Trustees of the Marist Brothers (Ruling) [2024] VCC 1859 (Link to AUSTLII).
Gregory Barclay, the plaintiff, sought relief from the compromise of a claim for personal injury damages recorded in a Deed entered into on 12 November 2015 (“the previously settled cause of action”) with the defendant, the Trustees of the Marist…
On November 28, 2024, China’s National Medical Products Administration (NMPA, 国家药品监督管理局), China’s equivalent of the U.S. Food and Drug Administration, issued the Draft Administrative Measures for Management of Medical Representatives for public comment (the Draft Management Measures, 医药代表管理办法) in conjunction with six other government agencies. The Draft Management Measures were issued for public comment, with…
Join us for the 10th Annual Nashville Healthcare Fraud Conference, hosted by Bass, Berry & Sims and the Tennessee Hospital Association. This highly anticipated, complimentary virtual program will take place during the mornings of December 12 and 13 and is approved for 9.5 hours of CLE credit, including ethics.…
The U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) announced on December 3 that it imposed a $1.19 million penalty on Gulf Coast Pain Consultants, a pain management practice in Florida, following a security breach that affected over 34,000 individuals.
Gulf Coast filed a breach notification report with OCR, as required…
